Indefinite Delivery Contract SPE2DR25D2203

Award Date 9/1/25
Last Date to Order 12/31/36
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The federal contract IDV award SPE2DR25D2911 is a single-award Indefinite Delivery Contract (IDC) between the Defense Logistics Agency (DLA) Troop Support Medical and Amerisourcebergen Drug Corp, a major pharmaceutical distributor, with a ceiling value of $999,999,999 and a performance period through December 2036. The contract aims to establish a Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) that will provide worldwide pharmaceutical support, including brand-name,...
The federal contract IDV award SPE2DR25D6029 is a single-award Indefinite Delivery Contract (IDC) between the Defense Logistics Agency (DLA) Troop Support Medical and Amerisourcebergen Drug Corp. The $999,999,999 contract, which runs through December 2036, covers the provision of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This includes specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and...
The federal contract IDV award SPE2DR25D2006 is a single-award Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a 30-month base period with three 30-month option periods, for a total potential value of $999,999,999.00 through December 2036. The purpose of this IDC is to establish a Pharmaceutical Prime Vendor...
The federal contract IDV award SPE2DR25D2228 is a single-award Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has a ceiling value of $999,999,999 and runs through December 2036, providing a broad range of pharmaceutical products and medical supplies to support various Department of Defense (DoD) customers, the U.S. Coast Guard, and other government agencies...
The federal contract IDV award SPE2DR25D3801 is a single-award Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $999,999,999, has a 30-month base period and three 30-month option periods, for a total potential period of performance through December 2036. The IDC serves as a primary vehicle for...
The federal contract IDV award SPE2DR25D2209 is a single-award Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp. The contract, valued at $999,999,999, aims to establish a Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) to provide worldwide pharmaceutical support to various DoD customers, including the Defense Health Agency, U.S. Coast Guard, and U.S. Naval Fleet. The contract...
The federal contract IDV award SPE2DR25D3304 is a single-award Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $999,999,999, has a period of performance through December 31, 2026 and serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs...
The federal contract IDV award is for an Indefinite Delivery Contract (IDC) between the Defense Logistics Agency (DLA) Troop Support Medical and Amerisourcebergen Drug Corp. The contract, valued at $999,999,999, has a period of performance running through December 2036 and provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract aims to establish Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN...
The federal contract IDV award SPE2DU25D7051 is a single-award Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,999,999,999, aims to establish a Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) to provide worldwide pharmaceutical support to various DoD customers, including the Defense Health...
The federal contract IDV award, SPE2DR25D1992, is a single-award Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $999,999,999, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical and has an ultimate completion date of December 31, 2036. The contract's purpose is to establish a Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) to provide...

The federal contract IDV award SPE2DR25D2203 is an Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $999,999,999 and a period of performance through December 31, 2036.

The contract serves as the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), providing worldwide pharmaceutical support to various Department of Defense (DoD) customers, including the Defense Health Agency (DHA), U.S. Coast Guard, and U.S. Naval Fleet. The contracted products and services encompass a comprehensive range of pharmaceutical and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The contract is structured as a firm-fixed price, requirements-type contract with a 30-month base period and three 30-month option periods, with the intention of awarding multiple primary suppliers for separate regions as well as a single backup supplier. The original solicitation was issued as an unrestricted, fully competitive acquisition with a Lowest Price Technically Acceptable (LPTA) evaluation criteria.

Generated 6/6/25, 10:08 AM